FOIA to the U.S. Department of Health and Human Services seeking communications regarding companies developing vaccines or treatments for coronavirus.

FOIA to the Food and Drug Administration seeking communications regarding companies developing vaccines or treatments for coronavirus.

FOIA to the Centers for Disease Control and Prevention seeking communications regarding companies developing vaccines or treatments for coronavirus.

FOIA to the National Institutes of Health seeking communications regarding companies developing vaccines or treatments for coronavirus.

FOIA to the National Institute of Allergy and Infectious Diseases seeking communications regarding companies developing vaccines or treatments for coronavirus.

FOIA to the Food and Drug Administration (FDA) seeking records sufficient to identify the date Gilead submitted its request for orphan-drug designation for remdesivir as a treatment for COVID-19.

FOIA to the Food and Drug Administration seeking records sufficient to identify, with respect to requests for orphan-drug designation for treatments for COVID-19, the requester’s name, the date of the request, and the name of the treatment.

FOIA to multiple agencies seeking Rep. Mark Meadows’s text messages with agency officials in light of Meadows’s expected appointment to White House Chief of Staff.

FOIA to multiple agencies seeking Rep. Mark Meadows’s emails with agency officials in light of Meadows’s expected appointment to White House Chief of Staff.

The Centers for Disease Control and Prevention stated that it had no records responsive to American Oversight's request for records reflecting directives about external communications regarding Coronavirus.